miRoncol Health
Back to news
February 7, 2025

OBIO Investment Summit Presentation

From the miRoncol archive: This historical update may contain promotional language or research findings that do not describe the current service. Retrospective research results do not establish prospective screening performance, and references to scientific prizes do not imply evaluation or endorsement of miRoncol or miCheckup. Do not rely on this archive for healthcare decisions; use the current product information and discuss screening decisions with a healthcare professional.

miRoncol Health was delighted to present at the 2025 OBIO Investment Summit, a premier event for the Canadian life sciences, healthcare, and innovation industries. The summit was held in Toronto from February 5-7, 2025, and provided an invaluable forum for networking, insightful presentations, and fostering collaborations between leading investors, innovative entrepreneurs, and influential business leaders.

Our team was honored to share our advancements and vision within this dynamic environment, connecting with key stakeholders who are shaping the future of healthcare in Canada and beyond. The opportunity to engage with such a diverse group of industry professionals further strengthens our commitment to driving innovation in early cancer detection.